Discipline Decisions (May 2026)

• from on or about January 5, 2024 to on or about April 23, 2025, she billed (or permitted, consented to, or approved, expressly or by implication, the billing of) compliance aid medications to certain identified patients at more frequent intervals than the compliance packages were actually dispensed; and,
• from on or about January 5, 2024 to on or about April 23, 2025, she created (or permitted, consented to, or approved, expressly or by implication, the creation of) false and/or misleading records indicating that compliance aid medications dispensed to certain identified patients were dispensed at more frequent intervals than the compliance packages were actually dispensed.

In particular, the Panel found that the Registrant:

• failed to maintain a standard of practice of the profession
• failed to keep records as required respecting her patients or practice;
• falsified a record related to her practice or a person’s health record;
• signed or issued in her professional capacity, a document that she knew or ought to have known contained a false or misleading statement;
• submitted an account or charge for services or products that she knew or ought to have known was false or misleading;
• engaged in conduct or performed an act relevant to the practice of pharmacy that, having regard to all the circumstances, would reasonably be regarded by members as dishonourable and unprofessional.

The Panel imposed an Order, as follows:

1. A reprimand;
2. That the Registrar is directed to impose specified terms, conditions or limitations on the Registrant’s Certificate of Registration as follows:
   1. The Registrant shall successfully complete, at her own expense and within twelve (12) months of the date of this Order: a course with Gail E. Siskind Consulting Services or another ethics consultant approved by the College, to address the professional misconduct arising from this matter, to be designed by the consultant. The following terms shall apply to the course:
      1. The number of sessions shall be at the discretion of the consultant, but shall be no fewer than three;
      2. The manner of attendance at the session(s) (e.g., in person, via videoconference etc.) is a matter to be discussed in advance between the Registrant and the consultant, but shall ultimately be at the discretion of the consultant;
      3. Successful completion of the course will include completion of an essay, acceptable to the Registrar, addressing the professional misconduct arising from this matter;
      4. The essay shall be at least 1000 words in length. The Registrant shall be responsible for the cost of review by the consultant to assist the Registrar to determine whether the essay is acceptable, up to a maximum of $500; and
      5. The Registrant shall require the consultant to report the results of the course to the College no later than thirteen (13) months from the date of this Order.
   2. That the Registrant successfully complete, within twelve (12) months of the date of this Order, a mentorship, with a mentor approved by the College, regarding the issues raised by the facts and findings of professional misconduct in this case. The mentorship must comply with the following terms:
      1. Within three months of the date of this Order, the College shall assign the Registrant a practice mentor and the Registrant shall retain the practice mentor at her own expense;
      2. The Registrant shall meet at least three times with the practice mentor, at the Registrant’s pharmacy, for the purpose of reviewing the Registrant’s practice with respect to the role and responsibilities of a Designated Manager arising from this matter, including but not limited to: billing, documentation, and record-keeping;
      3. The Registrant shall provide the practice mentor with the following documents related to this proceeding:
         1. The Agreed Statement of Facts;
         2. The Joint Submission on Order; and
         3. The Panel’s Decision and Reasons, if and when available;
      4. The Registrant shall develop a learning plan with the mentor to comprehensively address the remediation required;
      5. The Registrant shall demonstrate to the mentor that she has successfully achieved all of the goals of the learning plan;
      6. The Registrant shall require the mentor to report the results of the Mentorship Program to the College, in writing and at the Registrant’s own expense, no later than thirteen (13) months from the date of this Order. Such report shall include, but is not limited to:
         1. The learning plan; and
         2. The mentor’s assessment of the Registrant’s success in meeting the goals of the learning plan.
   3. That the Registrant shall be prohibited from acting as a Designated Manager in any pharmacy until the Registrant has completed the remediation outlined above in paragraph 2(a) or 2(b), above, whichever is successfully completed first.
3. That the Registrar suspend the Registrant’s Certificate of Registration for a period of three (3) months. with one (1) month of the suspension to be remitted on condition that the Registrant complete the remedial training as specified in paragraph 2(a) and 2(b). The suspension shall commence on April 13, 2026, and shall continue until June 13, 2026, inclusive. If the remitted portion of the suspension is required to be served by the Registrant because he fails to complete the remedial requirement specified in paragraph 2(a) and 2(b) that portion of the suspension shall commence on April 14, 2027, and shall continue until May 14, 2027, inclusive. If the time for completing the remedial steps in paragraph 2(a), and/or 2(b) above, is extended by the Registrar, the date on which the remitted portion of the suspension shall commence, if required, shall be adjusted accordingly.
4. Costs to the College in the amount of $10,000.

In its reprimand, the Panel noted that the practice of pharmacy is a privilege that carries with it significant obligations to the public, the profession, and oneself. The Panel also noted that the Registrant eroded public trust in the profession by engaging in misconduct.

The Panel expressed that as a Registrant, she is expected to comply with her professional, legal, and ethical obligations, and the standards of practice of this profession. The Panel found that the Registrant failed to meet those obligations in her responsibilities as both a pharmacist and Designated Manager.

The Panel noted their concern with the seriousness of the allegations and the conduct that the Registrant had admitted to engaging in. The Panel found that the Registrant failed to meet her professional responsibilities as both a pharmacist and a Designated Manager.

Specifically, the Panel found that the Registrant failed to maintain the standards of practice of the profession, failed to keep accurate and complete records, and engaged in inappropriate billing practices. As a pharmacist and Designated Manager, the Panel stated that the Registrant is accountable for ensuring that her practice complies with all applicable laws, as well as for establishing and maintaining policies and procedures that align with those legal and professional requirements.

The Panel expressed its hope that the discipline process will cause the Registrant to reflect on her practice and will motivate her to make positive changes. The Panel expects that they will not see the Registrant before a Discipline Committee Panel again.

• Submitted (or permitted, consented to, or approved, expressly or by implication, the submission of) an account or charge for services or products that he knew and/or ought to have known was false or misleading with respect to one or more of certain identified drugs and/or products and/or one or more of certain identified claims to the Ontario Drug Benefit Program;
• Falsified (or permitted, consented to or approved, expressly or by implication, the falsification of) a record regarding his patients and/or his practice with respect to one or more of certain identified drugs and/or products and/or one or more of certain identified claims to the Ontario Drug Benefit Program;
• Signed or issued (or permitted, consented to, or approved, expressly or by implication, the signing or issuance of), in his professional capacity, a document he knew and/or ought to have known contained a false and/or misleading statement with respect to one or more of certain identified drugs and/or products and/or one or more of certain identified claims to the Ontario Drug Benefit Program; and
• Failed to keep records as required regarding his patients and/or his practice with respect to one or more of certain identified drugs and/or products and/or one or more of certain identified claims to the Ontario Drug Benefit Program.

In particular, the Panel found that the Registrant:

• Failed to maintain a standard of practice of the profession;
• Failed to keep records as required respecting his patients and/or practice;
• Falsified (or permitted, consented to or approved, expressly or by implication, the falsification of) a record relating to his practice and/or a person’s health record;
• Signed or issued (or permitted, consented to, or approved, expressly or by implication, the signing or issuance of), in his professional capacity a document that he knew or ought to have known contained a false or misleading statement;
• Submitted (or permitted, consented to, or approved, expressly or by implication, the submission of) an account or charge for services or products that he knew or ought to have known was false or misleading;
• Engaged in conduct or performed an act relevant to the practice of pharmacy that, having regard to all the circumstances, would reasonably be regarded by members as disgraceful, dishonourable and unprofessional.

After hearing submissions with respect to the order to be imposed on October 30, 2025, the Panel issued its Order in a decision dated February 26, 2026.

The Panel imposed an Order, as follows:

1. A reprimand;
2. The Registrar be directed to suspend the Registrant’s Certificate of Registration for a period of eighteen (18) months. The suspension shall commence on the date that this Order becomes final and shall run, without interruption, for eighteen (18) months;
3. The Registrar be directed to impose specified terms, conditions and limitations on the Registrant’s Certificate of Registration:
   1. That the Registrant shall successfully complete at his own expense, an ethics course with Gail E. Siskind Consulting Services or another professional ethics consultant acceptable to the College, to be designed by the consultant for the purpose of addressing the professional and ethical misconduct issues arising in this case. The following terms shall apply to the ethics course:
      1. the number of sessions shall be at the discretion of the consultant but shall be no fewer than three (3) sessions;
      2. the manner of attendance at the sessions (e.g. in person, virtually, etc.) shall be discussed in advance between the Registrant and the consultant, but ultimately shall be at the discretion of the consultant;
      3. the Registrant shall provide the consultant a copy of the Panel’s Reasons for Decision on Findings, dated November 1, 2024, and these Reasons for Decision on Order in advance of the course;
      4. the successful completion of the ethics course shall include an essay that is acceptable to the Registrar, addressing the professional and ethical misconduct issues arising in this case;
      5. the essay shall be at least 1,000 words in length and the Registrant shall be responsible for the cost of the consultant’s review to assist the Registrar to determine whether the essay is acceptable, up to a maximum of $500.00; and
      6. the Registrant shall request a report from the consultant confirming that he has completed the essay and the course to the consultant’s satisfaction, and he shall provide a copy of the consultant’s report to the College no later than twelve (12) months from the date that this Order becomes final.
   2. That for a period of five (5) years, commencing on the date that this Order becomes final, the Registrant:
      1. shall be prohibited from having any proprietary interest in a pharmacy of any kind and/or receiving remuneration for his work as a pharmacist other than remuneration on an hourly or weekly basis;
      2. shall be prohibited from acting as a Designated Manager in any pharmacy;
      3. shall be required to notify the College in writing of the names, addresses and telephone numbers of all employer(s) within fourteen (14) days of commencing employment in a pharmacy;
      4. shall provide his pharmacy employer with a copy of the Discipline Committee’s Reasons for Decision on Findings in this matter dated November 1, 2024, and these Reasons for Decision on Order; and
      5. shall only engage in the practice of pharmacy for an employer who agrees to write to the College within fourteen (14) days of the Registrant commencing employment, confirming that it has received a copy of the required documents identified in subparagraph 3(b)(iv), and confirming the nature of the Registrant’s remuneration.
4. The Registrant shall pay a fine of $15,000.00 to the Minister of Finance, within thirty (30) days from the date that this Order becomes final. The Registrant shall notify the College and provide information acceptable to the College that the fine was paid, no later than seven (7) days after the date that the fine has been paid.
5. Costs to the College in the amount of $133,473.13.

The reprimand in this matter was administered on May 27, 2026.

In its reprimand, the Panel noted that it made findings that the Registrant indirectly participated in unsubstantiated billings and invalid claims by directing and/or permitting the Designated Manager to submit those claims on behalf of the Pharmacy. This conduct reflects a serious lapse in judgment and a significant breach of the professional and ethical standards governing the practice of pharmacy. The submission of more than $140,000 in unsubstantiated claims, including over $95,000 to the Ontario Drug Benefit Program, is a serious matter that undermines public trust and harms the reputation of the profession.

The Panel explained that, as a pharmacist, the Registrant is entrusted with upholding high standards of care, supervision, and regulatory compliance to protect patients and maintain public confidence in the profession. As a director, shareholder, and owner of the Pharmacy, he was also responsible for providing appropriate oversight of its operations and ensuring compliance with applicable legal requirements and ethical standards. He failed to meet these responsibilities. The Panel expressed that it is particularly concerned by the Registrant’s lack of accountability, despite his direct involvement in the Pharmacy’s financial oversight.

The Panel observed that the Registrant is expected to take this reprimand seriously, reflect on his conduct, and learn from these findings. The Panel expects that the Registrant will ensure this type of misconduct does not occur again and that he will uphold the standards of the profession going forward.